
Silence Therapeutics plc “another US grant bringing the total up to 10 granted in the USA” Ali Mortazavi, CEO
Silence Therapeutics plc, LON:SLN a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announced today that the